Knowledge · Supplements
Silymarin and silibinin: membranes, rRNA and clinical evidence
Extract composition, stereochemistry, oral and IV exposure, membrane experiments, OATP1B3, rat Pol I/rRNA, redox and fibrosis pathways. Primary liver trials, negative endpoints, interactions and formulation limits.